Notice of Change to the Eligibility of Foreign Components in PA-17-111 " Neuroscience Research on Drug Abuse (R01)"

Notice Number: NOT-DA-17-041

Key Dates
Release Date: May 31, 2017  

Related Announcements
PA-17-111

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to change the Eligibility Information of Foreign Institutions to allow foreign components for PA-17-111, "Neuroscience Research on Drug Abuse (R01)."

The following section of PA-17-111 has been revised:

Part 2. Section III. Eligibility Information
1. Eligible Applicants

Foreign Institutions

Currently reads:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Modified to read:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Roger Sorensen, Ph.D., M.P.A.
National Institute on Drug Abuse (NIDA)
Telephone: 301- 443-3205
Email: rsorense@nida.nih.gov